
| Specification | Detail |
| Category | High-Concentration Combinatorial Research |
| Product Name | Cagritirz (Cagrilintide + Tirzepatide Blend) |
| Quantity | 40mg (Total Active API Concentration) |
| Formulation | Sterile Lyophilised Solution in Bacteriostatic Water |
| Delivery Method | 3ml Precision Reconstituted Pen |
| CAS Number | 2023788-19-2 (Tirzepatide); 1415456-99-3 (Cagrilintide) |
| Molecular Formula | $C_{225}H_{348}N_{48}O_{68}$ (Tirzepatide) / $C_{165}H_{264}N_{44}O_{56}S_{2}$ (Cagrilintide) |
| Molecular Weight | $\approx 4813.52 \text{ g/mol}$ (Tirzepatide) / $\approx 4493.1 \text{ g/mol}$ (Cagrilintide) |
| Purity | >99% (HPLC Analysis) |
£299.00 Original price was: £299.00.£269.00Current price is: £269.00.
Abstract The Cagritirz 40mg peptide pen represents a high-concentration research instrument, combining the pharmacological profiles of Cagrilintide and Tirzepatide. This “super-agonist” blend is designed for advanced metabolic investigations requiring higher molar concentrations to probe the upper limits of receptor saturation. By synergising the dual incretin action of Tirzepatide (GLP-1/GIP) with the amylin analogue properties of Cagrilintide, this compound facilitates the study of profound weight modulation and glycaemic control pathways. The 40mg concentration is specifically optimised for dose-escalation studies and high-resistance models where standard concentrations may fail to elicit observable phenotypic changes in adipose tissue or gastric motility.
Primary Biological Pathway: High-Affinity Receptor Saturation The 40mg formulation is critical for research focusing on receptor occupancy theory. At this concentration, researchers can investigate the ceiling effects of the Glucagon-like Peptide-1 (GLP-1), Glucose-dependent Insulinotropic Polypeptide (GIP), and Amylin receptors. The primary interest here is determining whether simultaneous activation of these three pathways exhibits diminishing returns or if a linear dose-response relationship is maintained at supraphysiological levels. This is particularly relevant for studying “catecholamine resistance” in adipose tissue, where standard doses often fail to overcome metabolic adaptation.
Secondary Research Finding: Lipotoxicity and Cellular Stress This high-concentration variant is frequently employed in studies examining lipotoxicity—the metabolic damage caused by excessive lipid accumulation in non-adipose tissues. The robust GIP component of Tirzepatide enhances lipid storage capacity in adipocytes, while the Cagrilintide component drives oxidation. Research suggests this combination at 40mg may rapidly reverse markers of hepatic steatosis (fatty liver) in obese murine models by aggressively redirecting lipid substrates, a mechanism not fully observable with lower-dose interventions.
Tertiary Research Finding: Neuroendocrine Plasticity Cagritirz 40mg allows for the investigation of neuroplasticity within the hypothalamus and brainstem. High-dose amylin and GLP-1 agonism have been hypothesised to induce structural changes in the neural pathways governing appetite. Researchers are using this compound to map the expression of c-Fos (a marker of neuronal activity) in the solitary tract nucleus, seeking evidence of long-term “rewiring” of satiety set-points that persists even after the cessation of the peptide administration.
Long-term Genomic and Safety Observations Given the potency of the 40mg concentration, safety pharmacology studies are vital. Current research is monitoring for potential “off-target” effects, such as gastrointestinal smooth muscle hypertrophy or pancreatic enzyme elevation. Preliminary genomic data suggests that despite the high concentration, the molecule maintains a high specificity profile, with little evidence of interaction with unintended receptor families. However, rigorous monitoring of calcitonin levels remains a standard protocol in all rodent studies involving this compound.
Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The high concentration requires stringent purification processes to prevent aggregation of the peptide chains.
Appearance: The 3ml pen contains a clear, viscous, sterile liquid. Note that due to the high peptide concentration, the solution may appear slightly more viscous than lower-dose variants.
Precision: The pen mechanism allows for precise volumetric delivery, crucial when handling high-potency solutions where even a microlitre variance equates to a significant dose difference.
Storage: Maintain strictly at 2∘C to 8∘C.
Refrigeration and Shelf Life
The Cagritirz 40mg Pen is a high-value biological reagent that demands strict cold-chain adherence. It must be stored at 2∘C to 8∘C. The shelf life is 12 months in its sealed state. Due to the high concentration, the solution is more prone to precipitation if left at room temperature for extended periods after opening. Therefore, it is strongly advised to use the product within 28 days of the first seal breach and to return it to refrigeration immediately after every use.
Shipping Stability
The molecular stability of Cagritirz allows it to withstand ambient temperatures for up to 28 days.
This resilience is due to the specific pH buffering of the solution, ensuring the product arrives at your laboratory with its bioactivity fully intact.
Freezing Warning Absolutely do not freeze
Freezing is catastrophic for this formulation. The high concentration of peptide molecules increases the risk of irreversible aggregation (fibrillation) upon thawing. If frozen, the peptide will likely precipitate out of solution, appearing as cloudy white strands, and must be discarded immediately as it is unfit for research.
The Cagritirz 40mg Pen offers a unique advantage for high-dose studies: Volumetric Efficiency. To achieve an equivalent dose using standard 10mg or 15mg vials would require injecting large volumes of liquid, which can be confounding in small animal models (causing stress or tissue distension).
This 40mg pen delivers a high payload in a minimal volume, adhering to the “3Rs” of animal research (Replacement, Reduction, Refinement) by minimising subject distress. It provides a sterile, pre-validated solution that allows for high-dose protocols to be executed with the same precision as micro-dose studies.
For researchers conducting dose-escalation or comparative efficacy trials, we recommend referencing:
Cagritirz 15mg: (For mid-range dosing controls).
Cagrilintide 10mg: (For isolating the amylin-specific variable).
This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and permanent account suspension, in accordance with UK regulations regarding research chemicals.
Explore our high-purity compounds — including Retatide (Retatrutide 30 mg), Semaglutide, and more.
Fast UK shipping. Lab-tested quality. Strictly for research use only.